EntroGen is a Los Angeles-based biotechnology company with a primary focus on molecular diagnostics in the areas of hematology and oncology. EntroGen has a growing commercial portfolio of real-time PCR and NGS based tests, with many of its products being used to guide and monitor targeted therapies for various malignancies. Through a network of distributors, EntroGen’s footprint reaches every corner of the globe to deliver reliable and innovative tools to researchers and clinicians.